⸺ Celvora
Cagrilintide
Long-acting amylin analogue researched for appetite regulation and weight management, often paired with GLP-1 agonists.
Secure checkout. Free shipping on orders over £100.
Independently tested
COA on request
Fast dispatch
Order before 2pm
Research use only
Not for human consumption
⸺ Overview
About Cagrilintide
Cagrilintide is a synthetic long-acting analogue of amylin, studied for satiety signalling and combined effects with GLP-1 agonists.
⸺ Mechanism of Action
How it works
Cagrilintide acts on amylin and calcitonin receptors in the central nervous system, modulating satiety and gastric motility.
⸺ Research
Areas of study
Appetite signalling
Rodent studies demonstrate reduced food intake via central amylin-receptor pathways.
Combination with GLP-1 agonists
Preclinical work pairing Cagrilintide with GLP-1 agonists reports additive effects.
Gastric emptying
Animal models show slower gastric emptying.
⸺ Details
Specification
- CAS
- 1415456-99-3
- Intended use
- Research use only.
- Storage
- Lyophilised: cool, dry. Reconstituted: 2–8°C.
- Solubility
- Vial holds up to 3mL.
- Shelf life
- Lyophilised: 24 months.
- Handling
- Sterile technique throughout.
You might also research
View all →
Retatrutide
Investigational triple receptor agonist targeting GLP-1, GIP and glucagon — studied for appetite control, energy expenditure and glucose balance.
Tirzepatide
Dual GLP-1 and GIP receptor agonist studied in preclinical models for glucose regulation, insulin sensitivity and energy balance.
Semaglutide
Synthetic analogue of the GLP-1 hormone used in research to study glucose regulation, insulin secretion and the incretin response.